Latest Multiple myeloma Stories
In-demand research report “Treating Refractory Hematological Malignancies - Multiple Myeloma (MM): New Treatment Options Driving In-Licensing and M&A” drawn up by MP Advisors has been
Treating Refractory Hematological Malignancies – Multiple Myeloma (MM): New Treatment Options Driving In-Licensing and M&A is the new research report added to ReportsnReports.com store.
Researchers have discovered why multiple myeloma, a difficult to cure cancer of the bone marrow, frequently recurs after an initially effective treatment that can keep the disease at bay for up to several years.
A gene that helps control the aging process by acting as a cell's internal clock has been linked to cancer by a major new study.
The update will result in improved patient prognoses, better informed patient care decisions and reduced costs. (PRWEB) July 22, 2013 Signal
- A poem in which the author retracts something said in an earlier poem.